These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1564957)

  • 1. Effect of melphalan against self-renewal capacity of leukemic progenitors in acute myeloblastic leukemia.
    Demur C; Chiron M; Saivin S; Attal M; Dastugue N; Bousquet C; Galinier JL; Colombies P; Laurent G
    Leukemia; 1992 Mar; 6(3):204-8. PubMed ID: 1564957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
    Nagata K; Tohda S; Suzuki T; Nara N
    Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant interferons on colony formation of blast progenitors in acute myeloblastic leukemia.
    Takanashi M; Motoji T; Oshimi K; Mizoguchi H
    Exp Hematol; 1987 Oct; 15(9):946-51. PubMed ID: 2443379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU).
    Allieri MA; Douay L; Deloux J; Smadja N; Najman A; Gorin NC
    Exp Hematol; 1990 Sep; 18(8):911-5. PubMed ID: 2387341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
    Motta MR; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli RM
    Exp Hematol; 1997 Nov; 25(12):1261-9. PubMed ID: 9357970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
    Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia.
    Nara N; Chen GJ; Murohashi I; Tohda S; Imai Y; Tomiyama J; Nagata K; Suzuki T; Tanikawa S; Shiina S
    Exp Hematol; 1992 Aug; 20(7):904-8. PubMed ID: 1628709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
    Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of H-7 and staurosporine on proliferation and self-renewal of acute myeloid leukemia progenitors.
    Laredo J; Demur C; Muller C; Saivin S; Cassar G; Bousquet C; Dastugue N; Jaffrézou JP; Colombies P; Laurent G
    Leukemia; 1993 Jun; 7(6):813-20. PubMed ID: 8501977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S; Pettit GR; Howe C; McCrady C
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
    Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.